Are Metformin Doses Used in Murine Cancer Models Clinically Relevant?

被引：135

作者：

Chandel, Navdeep S. ^{[1
]}

Avizonis, Dania ^{[2
]}

Reczek, Colleen R. ^{[1
]}

Weinberg, Samuel E. ^{[1
]}

Menz, Stephan ^{[4
]}

Neuhaus, Roland ^{[4
]}

Christian, Sven ^{[3
]}

Haegebarth, Andrea ^{[3
]}

Algire, Carolyn ^{[3
]}

Pollak, Michael ^{[2
]}

机构：

[1] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA

[2] McGill Univ, Goodman & Segal Canc Ctr, 3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada

[3] Bayer Pharma AG, Global Therapeut Res Grp Oncol 2, GDD, BPH, Mullerstr 178, D-13353 Berlin, Germany

[4] Bayer Pharma AG, DMPK, Global Early Dev, GDD,BPH, Mullerstr 178, D-13353 Berlin, Germany

来源：

CELL METABOLISM | 2016年 / 23卷 / 04期

关键词：

BIGUANIDES; GROWTH;

D O I：

10.1016/j.cmet.2016.03.010

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：569 / 570

页数：2

共 10 条

[1] Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo
Algire, C.
Amrein, L.
Bazile, M.
David, S.
Zakikhani, M.
Pollak, M.
[J]. ONCOGENE, 2011, 30 (10) : 1174 - 1182
[2] Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Birsoy, Kivanc
Possemato, Richard
Lorbeer, Franziska K.
Bayraktar, Erol C.
Thiru, Prathapan
Yucel, Burcu
Wang, Tim
Chen, Walter W.
Clish, Clary B.
Sabatini, David M.
[J]. NATURE, 2014, 508 (7494) : 108 - +
[3] Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
Buzzai, Monica
Jones, Russell G.
Amaravadi, Ravi K.
Lum, Julian J.
DeBerardinis, Ralph J.
Zhao, Fangping
Viollet, Benoit
Thompson, Craig B.
[J]. CANCER RESEARCH, 2007, 67 (14) : 6745 - 6752
[4] Metformin: From Mechanisms of Action to Therapies
Foretz, Marc
Guigas, Bruno
Bertrand, Luc
Pollak, Michael
Viollet, Benoit
[J]. CELL METABOLISM, 2014, 20 (06) : 953 - 966
[5] Clinical Pharmacokinetics of Metformin
Graham, Garry G.
Punt, Jeroen
Arora, Manit
Day, Richard O.
Doogue, Matthew P.
Duong, Janna K.
Furlong, Timothy J.
Greenfield, Jerry R.
Greenup, Louise C.
Kirkpatrick, Carl M.
Ray, John E.
Timmins, Peter
Williams, Kenneth M.
[J]. CLINICAL PHARMACOKINETICS, 2011, 50 (02) : 81 - 98
[6] Serine Deprivation Enhances Antineoplastic Activity of Biguanides
Gravel, Simon-Pierre
Hulea, Laura
Toban, Nader
Birman, Elena
Blouin, Marie-Jose
Zakikhani, Mahvash
Zhao, Yunhua
Topisirovic, Ivan
St-Pierre, Julie
Pollak, Michael
[J]. CANCER RESEARCH, 2014, 74 (24) : 7521 - 7533
[7] Metformin Action: Concentrations Matter
He, Ling
Wondisford, Fredric E.
[J]. CELL METABOLISM, 2015, 21 (02) : 159 - 162
[8] Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
Kordes, Sil
Pollak, Michael N.
Zwinderman, Aeilko H.
Mathot, Ron A.
Weterman, Mariette J.
Beeker, Aart
Punt, Cornelis J.
Richel, Dick J.
Wilmink, Johanna W.
[J]. LANCET ONCOLOGY, 2015, 16 (07) : 839 - 847
[9] Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth
Levy, Jonathan
Cacheux, Walfran
Bara, Medhi Ait
L'Hermitte, Antoine
Lepage, Patricia
Fraudeau, Marie
Trentesaux, Coralie
Lemarchand, Julie
Durand, Aurelie
Crain, Anne-Marie
Marchiol, Carmen
Renault, Gilles
Dumont, Florent
Letourneur, Franck
Delacres, Myriam
Schmitt, Alain
Terris, Benoit
Perret, Christine
Chamaillard, Mathias
Couty, Jean-Pierre
Romagnolo, Beatrice
[J]. NATURE CELL BIOLOGY, 2015, 17 (08) : 1062 - U440
[10] Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
Wheaton, William W.
Weinberg, Samuel E.
Hamanaka, Robert B.
Soberanes, Saul
Sullivan, Lucas B.
Anso, Elena
Glasauer, Andrea
Dufour, Eric
Mutlu, Gokhan M.
Budigner, G. R. Scott
Chandel, Navdeep S.
[J]. ELIFE, 2014, 3

← 1 →